标签： Topline

Main Stories

Altimmune, Inc. (ALT) Discusses Topline 48-Week Results From IMPACT Phase IIb Trial of Pemvidutide in MASH – Slideshow

20/12/2025
admin

Altimmune, Inc. …

Main Stories

Nektar Therapeutics (NKTR) Discusses Topline Results From REZOLVE-AA Phase 2b Study of rezpegaldesleukin in Alopecia Areata – Slideshow

17/12/2025
admin

Nektar Therapeut…